清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Nonpharmacologic and Pharmacologic Treatments of Adults in the Acute Phase of Major Depressive Disorder: A Living Clinical Guideline From the American College of Physicians

医学 重性抑郁障碍 指南 认知行为疗法 精神科 人口 重症监护医学 物理疗法 认知 环境卫生 病理
作者
Amir Qaseem,Douglas K Owens,Itziar Etxeandia‐Ikobaltzeta,Janice Tufte,J. Thomas Cross,Timothy J Wilt
出处
期刊:Annals of Internal Medicine [American College of Physicians]
卷期号:176 (2): 239-252 被引量:113
标识
DOI:10.7326/m22-2056
摘要

Description: The purpose of this guideline from the American College of Physicians (ACP) is to present updated clinical recommendations on nonpharmacologic and pharmacologic interventions as initial and second-line treatments during the acute phase of a major depressive disorder (MDD) episode, based on the best available evidence on the comparative benefits and harms, consideration of patient values and preferences, and cost. Methods: The ACP Clinical Guidelines Committee based these recommendations on an updated systematic review of the evidence. Audience and Patient Population: The audience for this guideline includes clinicians caring for adult patients in the acute phase of MDD in ambulatory care. The patient population includes adults in the acute phase of MDD. Recommendation 1a: ACP recommends monotherapy with either cognitive behavioral therapy or a second-generation antidepressant as initial treatment in patients in the acute phase of moderate to severe major depressive disorder (strong recommendation; moderate-certainty evidence). Recommendation 1b: ACP suggests combination therapy with cognitive behavioral therapy and a second-generation antidepressant as initial treatment in patients in the acute phase of moderate to severe major depressive disorder (conditional recommendation; low-certainty evidence). The informed decision on the options of monotherapy with cognitive behavioral therapy versus second-generation antidepressants or combination therapy should be personalized and based on discussion of potential treatment benefits, harms, adverse effect profiles, cost, feasibility, patients' specific symptoms (such as insomnia, hypersomnia, or fluctuation in appetite), comorbidities, concomitant medication use, and patient preferences. Recommendation 2: ACP suggests monotherapy with cognitive behavioral therapy as initial treatment in patients in the acute phase of mild major depressive disorder (conditional recommendation; low-certainty evidence). Recommendation 3: ACP suggests one of the following options for patients in the acute phase of moderate to severe major depressive disorder who did not respond to initial treatment with an adequate dose of a second-generation antidepressant: • Switching to or augmenting with cognitive behavioral therapy (conditional recommendation; low-certainty evidence) • Switching to a different second-generation antidepressant or augmenting with a second pharmacologic treatment (see Clinical Considerations) (conditional recommendation; low-certainty evidence) The informed decision on the options should be personalized and based on discussion of potential treatment benefits, harms, adverse effect profiles, cost, feasibility, patients' specific symptoms (such as insomnia, hypersomnia, or fluctuation in appetite), comorbidities, concomitant medication use, and patient preferences.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
思源的应助被东风采纳,获得10
14秒前
李爱国的应助被东风采纳,获得10
14秒前
小蘑菇的应助被东风采纳,获得20
14秒前
深情安青的应助被东风采纳,获得10
14秒前
李爱国的应助被东风采纳,获得10
15秒前
ding的应助被东风采纳,获得10
26秒前
隐形曼青的应助被东风采纳,获得10
26秒前
wanci的应助被东风采纳,获得10
26秒前
充电宝的应助被东风采纳,获得10
26秒前
李健的应助被东风采纳,获得10
26秒前
赘婿的应助被东风采纳,获得10
27秒前
乐乐的应助被东风采纳,获得10
27秒前
汉堡包的应助被东风采纳,获得10
27秒前
科研通AI65的应助被东风采纳,获得10
27秒前
Maestro_S的应助被东风采纳,获得10
27秒前
岳晓燕完成签到 ,获得积分10
34秒前
小羊完成签到,获得积分0
41秒前
42秒前
AXX041795完成签到 ,获得积分10
42秒前
科研通AI6.4的应助被东风采纳,获得10
45秒前
orixero的应助被东风采纳,获得10
45秒前
彭于晏的应助被东风采纳,获得10
45秒前
Hello的应助被东风采纳,获得10
45秒前
余香的应助被东风采纳,获得10
45秒前
搜集达人的应助被东风采纳,获得10
45秒前
李爱国的应助被东风采纳,获得10
45秒前
科研通AI6.2的应助被东风采纳,获得10
45秒前
Hello的应助被东风采纳,获得10
45秒前
科研通AI2S的应助被东风采纳,获得10
46秒前
苹果完成签到 ,获得积分10
57秒前
Werner完成签到 ,获得积分10
1分钟前
啾啾完成签到 ,获得积分10
1分钟前
搜集达人的应助被东风采纳,获得10
1分钟前
天天快乐的应助被东风采纳,获得10
1分钟前
英姑的应助被东风采纳,获得10
1分钟前
NexusExplorer的应助被东风采纳,获得10
1分钟前
李健的小迷弟的应助被东风采纳,获得10
1分钟前
SciGPT的应助被东风采纳,获得10
1分钟前
科研通AI6.4的应助被东风采纳,获得10
1分钟前
彭于晏的应助被东风采纳,获得10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190280
求助须知:如何正确求助?哪些是违规求助? 9577382
关于积分的说明 21852440
捐赠科研通 7788866
什么是DOI,文献DOI怎么找? 3436315
关于科研通互助平台的介绍 2560109
邀请新用户注册赠送积分活动 2482945